Shared on19 Sep 25Fair value Increased 1.16%
Analysts raised their price targets for Allegion to $174.64, citing increased confidence in commercial demand and stable market conditions as non-residential activity recovers. Analyst Commentary Bullish analysts note reduced downside risk as the non-residential market in the Americas stabilizes and exits a recent soft patch.
Shared on04 Sep 25
Analysts have raised price targets for Allegion, citing recovered demand in its Americas non-residential market, improved industry fundamentals, and greater confidence in near-term revenue stability, resulting in an unchanged consensus price target of $172.64. Analyst Commentary Reduced downside risk as most of Allegion's Americas non-residential market has recovered from previous softness.
Shared on30 Apr 25Fair value Increased 2.42%
AnalystConsensusTarget has increased revenue growth from 3.6% to 4.6%.
Shared on23 Apr 25Fair value Decreased 1.60%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on16 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on09 Apr 25Fair value Increased 0.32%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on02 Apr 25Fair value Increased 1.29%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on26 Mar 25Fair value Increased 0.52%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on19 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on10 Mar 25Fair value Decreased 3.78%
AnalystConsensusTarget has decreased revenue growth from 5.9% to 3.5%.